bioRxivPathologyPreprint
Spatially Resolved Metabolites in Stable and Vulnerable Human Atherosclerotic Plaques Identified by Mass Spectrometry Imaging
E. H. Seeley, Z. Liu, S. Yuan, C. Stroope, E. D. Cockerham, N. Rashdan, A. C. Finney, D. Kumar, S. Das, B. Razani, W. Liu, J. G. Traylor, O. Rom, C. B. Pattillo, A. Yurdagul
Abstract
Impairments in carbohydrate, lipid, and amino acid metabolism drive features of plaque instability. However, where these impairments occur within the atheroma remains largely unknown. Therefore, we sought to characterize the spatial distribution of metabolites within stable and unstable atherosclerosis in both the fibrous cap and necrotic core. Atherosclerotic tissue specimens were scored based on the Stary classification scale and subdivided into stable and unstable atheromas. After performing mass spectrometry imaging (MSI) on these samples, we identified over 850 metabolite-related peaks. Using MetaboScape, METASPACE, and HMDB, we confidently annotated 170 of these metabolites and found over 60 of these were different between stable and unstable atheroma. We then integrated these results with an RNA-sequencing dataset comparing stable and unstable human atherosclerosis. Upon integrating our MSI results with the RNA-seq dataset, we discovered that pathways related to lipid metabolism and long-chain fatty acids were enriched in stable plaques, whereas reactive oxygen species, aromatic amino acid, and tryptophan metabolism were increased in unstable plaques. Acylcarnitines and acylglycines were increased in stable plaques whereas tryptophan metabolites were enriched in unstable plaques. Evaluating spatial differences in stable plaques revealed lactic acid in the necrotic core, whereas pyruvic acid was elevated in the fibrous cap. In unstable plaques, 5-hydroxyindole-acetic acid was enriched in the fibrous cap. Our work herein represents the first step to defining an atlas of metabolic pathways involved in plaque destabilization in human atherosclerosis. We anticipate this will be a valuable resource and open new avenues of research in cardiovascular disease. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=199 SRC="FIGDIR/small/494038v1_ufig1.gif" ALT="Figure 1"> View larger version (59K): org.highwire.dtl.DTLVardef@111368org.highwire.dtl.DTLVardef@1112d99org.highwire.dtl.DTLVardef@c8cdb2org.highwire.dtl.DTLVardef@13895d6_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A lipid atlas of human carotid atherosclerosis
A. M. Moerman, M. Visscher, … G. Van Soest·bioRxiv·Mar 9, 2020
- N-Terminal proteomics reveals distinct protein degradation patterns in different types of human atherosclerotic plaques
Lasse G. Lorentzen, Karin Yeung, … Michael J. Davies·Journal of Proteome ResearchPeer-reviewed·Dec 12, 2024
- Lipid Droplets of Human Carotid Atherosclerotic Plaques: Cholesteryl Arachidonate Core and Cytoskeletal Fibrotic Cover
Yilu Xu, Yang Wang, … Pingsheng Liu·bioRxiv·Aug 18, 2025
- The multifaceted process of human coronary atherosclerotic cap destabilisation
Laura E. Bruijn, Natascha Fonseca Neves, … Jan H.N. Lindeman·bioRxiv·Jul 21, 2024
- Proteomics and Ex Vivo Plaque Culture Identify the Insulin-Like Growth Factor Axis as a Regulator of Carotid Plaque Stability
Sara M. Jørgensen, Karen C. Yang-Jensen, … Lasse G. Lorentzen·bioRxiv·Oct 4, 2025
- Single-Cell Transcriptomic Profiling Unveils Critical Metabolic Alterations and Signatures in Progression of Atherosclerosis